European and U.S. drug regulators confirm no increased suicide risk associated with popular diabetes and weight loss drugs containing semaglutide or its analogs. ...
Wegovy addition to Medicare program not only shows the measures taken to deal with the health issues connected with obesity but also points out the accessibility and affordability barriers that still remain a problem within the healthcare system. ...